Table 1.
Antiviral |
Antireplicative viral activity Inhibition of entry virus into host cells |
Anti-inflammatory |
Increasing the expression of ACE-2 Inhibiting Toll-like receptor (TLR)–MYD88–NF-кB Reduction of C-reactive protein (CRP) |
Anti-thrombotic |
Decreased tissue factor expression Decreased platelet aggregation Increased thrombomodulin expression on endothelial cells |
Anti-fibrosis |
Inhibition of ROCK activity Reduction of TGFβ1 and PDGFβ |
Reduction of vascular endothelial dysfunction | Increasing endothelial NO synthase (eNOS) |